MEDICAL DEVICE NEWS MAGAZINE

The participation of Mount Sinai was directly caused by the FDA approval of RhoVac's Fast Track Designation.

Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.

Vesalius Cardiovascular Inc. notes the predetermined endpoints of the study were the feasibility and durability of VCI's papillary muscle anchoring device. Both endpoints were confirmed at the 180-day mark.

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

The LAVA Study, which stands for Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S.

Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery.

Launching in 2021, JAPSC will be led by Dr. Yeo Khung Keong as Editor-in-Chief and will be the official journal of the Society.

Data presented in two abstracts at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting.

F-Prime Capital led financing, joined by Questa Capital, Eight Roads, and Maverick Ventures

Willow notes an additional $26.8 Million in funding through a Series C Extension round, led by Endeavour Vision, alongside New Enterprise Associates, Pura Vida Investments, Purple Arch Ventures, Logos Capital, and Gaingels.

The Series C round was led by SoftBank Vision Fund 2* with participation from new investor Steadfast Capital Ventures, and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital.

The funding primarily supports the commercialization of Hominis® surgical robot in the United States following FDA De Novo marketing authorization.

SonoDepot, founded in 1985, is a St. Cloud, Florida based third-party service, maintenance, and repair organization with deep specialization in ultrasound equipment.

Katena Products, Inc. is a provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices.

PQ Bypass’ proprietary Detour platform for percutaneous femoral-popliteal bypass has been designated by the U.S. Food & Drug Administration as a Breakthrough Device.

Acquisitions were effective April 1, 2021, and will be subject to a long-term, triple net lease.

Fact.MR has recently compiled a report, which reveals that the vaccine delivery devices market globally is projected to reflect an impressive CAGR over the forecast period, 2017 – 2022.

Fact.MR’s detailed study on the rapid medical diagnostic kits market forecasts the landscape to accrue significant gains through 2031.

The Global Syringe Pump Market stood at USD19.60 billion in value terms in 2020 and is expected to grow at a CAGR of 7.21% and reach USD29.40 billion by 2026.

Generated $38.9 billion in 2019 and will increase to $70.0 billion in 2030.

President and Co-Founder Samarendra Mohanty, Ph.D. said, "We are honored to have such distinguished clinical experts in retinal disorders join us as advisers. Their guidance will be invaluable as we pioneer gene therapies to reprogram retinal cells and make them functionally active to regain vision."

Psaras breaks barriers as MedSupply’s first vice president, strengthening its commitment to superior service and offering innovative, cost-effective products.

Prior to joining ThermoTek, Chatman served as the Vice President of Strategic Contracting, Pricing, National Accounts, Reimbursement & Market Access for Wright Medical Group, a global medical device company focused on extremities and biologics which recently sold to Stryker for $4.7 billion.

SonoDepot, founded in 1985, is a St. Cloud, Florida based third-party service, maintenance, and repair organization with deep specialization in ultrasound equipment.

Katena Products, Inc. is a provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices.

PQ Bypass’ proprietary Detour platform for percutaneous femoral-popliteal bypass has been designated by the U.S. Food & Drug Administration as a Breakthrough Device.

Acquisitions were effective April 1, 2021, and will be subject to a long-term, triple net lease.

Across Health is a leading global omnichannel engagement consultancy.

February 19, 2021 SyBridge Technologies notes this transaction marks the further expansion by SyBridge in the mobility tooling industry, especially in the fast-growing lighting, fascia,...